Overview
The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this trial is to compare the ability of two doses of OT-551 ophthalmic solution and drug-free solution to safely and effectively treat geographic atrophy associated with age-related macular degeneration.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Othera PharmaceuticalsTreatments:
Ophthalmic Solutions
Pharmaceutical Solutions
Criteria
Inclusion Criteria:- have a clinical diagnosis of GA in one or both eyes;
- be of non-childbearing potential
Exclusion Criteria:
- have GA secondary to any condition other than AMD in the study eye;
- have a BCVA of 20/200 or worse in the non-study eye;
- have a history of or current choroidal neovascularization in either eye, or the need
for any study eye anti-angiogenic therapy;
- have any ocular condition in the study eye that would progress during the course of
the study and could affect central vision or other ocular conditions that may be a
confounding factor in this study;
- need to wear contact lenses in the study eye during the study;
- had confounding ocular surgery in the study eye;
- have concomitant treatment with any systemic or ocular medication that is known to be
toxic to the lens, retina, or optic nerve;